Introducing: GPS attacks. “By creating a false signal it is possible to fool a system into thinking it’s in a different place.” Russian oligarchs undertaking piracy? Check.
“Spoofing is currently used in Russia. Around the Kremlin, GPS devices typically show the location 20 miles away,” says Nathan Brubaker, head of the cyber-physical intelligence unit at FireEye.
Most of America is deteriorating economically.
Economic prosperity is concentrated in America’s elite ZIP Codes, but economic stability outside of those communities is rapidly deteriorating.
That’s the stark conclusion by Axios tech editor Kim Hart, in one of the most sobering pieces we have run in the eight months since we launched.
Posted in biotech/medical, genetics, neuroscience
THE numbers are stark. Cancer claimed the lives of 8.8m people in 2015; only heart disease caused more deaths. Around 40% of Americans will be told they have cancer during their lifetimes. It is now a bigger killer of Africans than malaria. But the statistics do not begin to capture the fear inspired by cancer’s silent and implacable cellular mutiny. Only Alzheimer’s exerts a similar grip on the imagination.
Confronted with this sort of enemy, people understandably focus on the potential for scientific breakthroughs that will deliver a cure. Their hope is not misplaced. Cancer has become more and more survivable over recent decades owing to a host of advances, from genetic sequencing to targeted therapies. The five-year survival rate for leukemia in America has almost doubled, from 34% in the mid-1970s to 63% in 2006-12. America is home to about 15.5m cancer survivors, a number that will grow to 20m in the next ten years. Developing countries have made big gains, too: in parts of Central and South America, survival rates for prostate and breast cancer have jumped by as much as a fifth in only a decade.
In Phase 1 trials, the BCG vaccine was able to create an environment that was able to temporarily restore insulin-producing beta cells.
For interesting science, like Scientifically.
We are keeping a close eye on this trial. If you would like to follow the outcome, Like us. Here is more information on the trial. https://clinicaltrials.gov/ct2/show/study/NCT02081326#contacts
